A Study of RO5045337 in Patients With Liposarcomas Prior to Debulking Surgery
NCT01143740
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Sarcoma
Interventions
DRUG:
RO5045337
Sponsor
Hoffmann-La Roche